Ion channels constitute a major group of therapeutic targets for diseases of unmet medical needs. IBC's 6th Annual Ion Channel Targets conference will address the most relevant issues facing the pharmaceutical industry regarding ion channel-based drug discovery, including both fact-based and perception-based issues. The agenda offers specific examples presented by numerous field experts illustrating the value and the practicality of re-positioning ion channels as a favorable class of targets for drug discovery.

Learn the latest on:

• Kv1.3 in disease applications
• Advancements in CRAC channel biology
• Ion channels involved in novel therapeutic applications

Scientific Advisory Board

• Neil Castle, Ph.D., Director of Biology, Icagen, Inc.
• Chuan-Chu Chou, Ph.D., Research Fellow, Schering Plough Research Institute
• Chris Mathes, Ph.D., Vice President, General Manager, Sophion Biosciences, Inc.
• Reinhold Penner, M.D., Ph.D., Professor, Cell & Molecular Signaling, University of Hawaii
• Alan Wickenden, Ph.D., Research Fellow, Johnson & Johnson PR&D
• Heike Wulff, Ph.D., Assistant Professor, Medical Pharmacology & Toxicology, University of California

View the Agenda

• Day One
• Day Two
• Day Three

View the other Tracks

• Protein Kinase Targets
• Assay and Screening Advances
• G-Protein Coupled Receptors